- $222.97m
- $168.94m
- $18.67m
Annual income statement for OmniAB, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 34.7 | 59.1 | 34.2 | 26.4 | 18.7 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 18.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 70.4 | 85.7 | 104 | 101 | 87.6 |
| Operating Profit | -35.6 | -26.6 | -69.4 | -74.5 | -69 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -34.4 | -26.1 | -64.4 | -71.4 | -66.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -27 | -22.3 | -50.6 | -62 | -64.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -27 | -22.3 | -50.6 | -62 | -64.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -27 | -22.3 | -50.6 | -62 | -64.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.235 | -0.194 | -0.508 | -0.606 | -0.587 |